The Board of Directors of JSW Dulux Limited will consider a proposal to alter its share capital through the sub-division or split of existing equity shares during a meeting scheduled for August 11, 2026. The company, formerly known as Akzo Nobel India Limited, aims to enhance liquidity and broaden investor participation by reducing the face value of its shares, pending approval from shareholders and relevant regulatory authorities.

In addition to the capital structure alteration, the Board will review and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The decision on the specific manner of the share split rests with the Board, which must also secure necessary statutory approvals under applicable laws before implementation.

Key Agenda Items

The meeting agenda includes critical corporate governance and financial disclosures:

Trading Window Status

As communicated in a previous filing dated June 26, 2026, the trading window for dealing in securities of JSW Dulux Limited remains closed for Designated Persons and their immediate relatives. This restriction has been effective since July 1, 2026. The trading window is scheduled to re-open forty-eight hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026.

Regulatory Compliance

This intimation is issued under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The update serves as a continuation of the earlier notification dated July 30, 2026, which initially announced the board meeting. The full text of the intimation is available on the company's website at www.jswdulux.com for public access and record-keeping purposes.

JSW Dulux Limited announced that Hemant Sahai ceased to be an Independent Director on August 2, 2026, marking the end of his consecutive second term on the Board. The departure is a routine succession event following the completion of the maximum permissible tenure for independent directors under corporate governance norms.

The intimation was filed with the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on August 3, 2026, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing references SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, as updated by SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Sahai’s cessation from the Board also resulted in his exit from all associated Board committees effective end of day on August 2, 2026. His previous committee positions included:

The updated composition of the Board and its committees remains unchanged for other directors. Parth Jindal continues as Chairman, while Rajiv Rajgopal serves as Joint Managing Director and CEO. Krishna Rallapalli continues as Wholetime Director and CFO, and Rohit G Totla serves as Wholetime Director.

The remaining Independent Directors are Anil Chaudhry, Namrata Kaul, Shantanu M Khosla, and Sutapa Banerjee. Kaustubh S Kulkarni continues as a Non-Executive Director. The Board structure maintains compliance with regulatory requirements for independent representation across key oversight functions.

Updated Committee Composition

Following Sahai’s exit, the committee structures have been adjusted to reflect the current membership. The Audit Committee is chaired by Namrata Kaul, with Anil Chaudhry, Shantanu M Khosla, and Sutapa Banerjee serving as members.

The Nomination and Remuneration Committee is chaired by Anil Chaudhry, with Namrata Kaul, Shantanu M Khosla, and Sutapa Banerjee as members. The Corporate Social Responsibility Committee, chaired by Namrata Kaul, includes members from both executive and non-executive ranks, including Rajiv Rajgopal, Krishna Rallapalli, and Rohit G Totla.

The Risk Management Committee now consists of nine members: Namrata Kaul, Anil Chaudhry, Sutapa Banerjee, Rajiv Rajgopal, Krishna Rallapalli, Rohit G Totla, Shantanu M Khosla, Sumit Khatuja, and Dr. Kumar Iyer. The Stakeholders Relationship Committee comprises Rajiv Rajgopal and Krishna Rallapalli.